Clarify New Guidelines for Prevnar 20 and Vaxneuvance

You’ll need to know which adults should get one of the new pneumococcal vaccines, Prevnar 20 or 15-valent Vaxneuvance...and when.

These conjugate vaccines may lead to longer-lasting and better immunity than Pneumovax 23 polysaccharide vaccine. CDC projects the new vaccines will reduce overall pneumococcal disease and healthcare costs.

This is leading to changes in pneumococcal guidelines for adults 65 and up...or 19 to 64 with risk factors (cancer, diabetes, smoking, etc).

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote